Navigation Links
Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications
Date:12/8/2009

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Mesenchymal Stem Cells, Advances & Applications

http://www.reportlinker.com/p0167257/Mesenchymal-Stem-Cells-Advances--Applications.html

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells.

MSCs are of intense therapeutic interest because they represent a population of cells with the potential treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.

This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. Additionally, this report provides guidance for companies that offer or wish to offer competitive stem cells products to this rapidly growing, well-funded research community.

I. Applications

A. Basic Research Applications

1. Directed Differentiation of Autologous MSCs towards Intra-Mesenchymal Lineages

2. Directed Differentiation of Autologous MSCs towards Extra-Mesenchymal Lineages

B. Supporting Hematopoietic Cells

C. Cell-Based Therapy Applications

1. Gene Transfer Applications

2. Allogenic Transplantation

3. Applications of MSCs for Osteochondral Repair

4. Applications of MSCs for Myocardiac Repair

5. Therapeutic Potential beyond Mesenchymal Lineages

D. Use of MSC in 3-D Scaffolds for Tissue Engineering Applications

II. Application Priorities

A. Overall

B. By Segment

1. Academic

2. Biotech

3. Pharma

III. Potential Labs/Customers

A. General MSC Research Labs

B. Osteogenic-Focused Research Labs

C. Myogenic and Myocardial-Focused Research Labs

D. Adipogenic-Focused Research Labs

E. Neuronal-Focused Research Labs

F. Immunology-Focused Research Labs

G. Commercial Labs

H. NIH Labs

IV. Companies Offering Human MSC Research Products, including Products Offered

A. Stem Cell Technologies

B. Thermo Scientific

C. Invitrogen

D. Celprogen

E. ScienCell Research Laboratories

F. Abcam

G. BD Biosciences

F. Millipore

V. Companies Offering Rodent MSC Research Products, including Products Offered

A. Cell Applications

B. Millipore

C. Celprogen

D. Cyagen Biosciences

E. ScienCell Research Laboratories

VI. Projected 5-Year Market Growth

A. Scientific Publication Trend Analysis

B. Grant Rate Trend Analysis

C. Patent Trend Analysis

VII. Mesenchymal Stem Cells as Tools for Drug Discovery

A. Companies Developing Toxicology Screening Platforms for Stem Cells

B. Advantages of Using Human MSCs for Drug Screening

C. Potential Drug Screening Advantages of Rodent MSCs

1. Acquisition, Handling, and Differentiation Advantages

2. Genetic Manipulation of MSCs

3. Potential for Genetically Engineered MSC Reporter Lines

VIII. Advantages of Serum Free Supplements for Use in MSC Research

IX. Research Product Opportunities and Suggestions

A. MSCs Derived from Alternative Sources than Bone Marrow

B. Novel RMSC Differentiation Kits

C. Mesenchymal Stem Cell Expansion Media

D. Mesenchymal Stem Cell Markers

E. Mesenchymal Growth Factors

F. Monoclonal Antibodies and Kits for Phenotyping RMSCs

G. Chips for MicroArray Analysis of Gene Expression in RMSCs

X. Conclusions

To order this report:

Pharmaceutical Industry: Mesenchymal Stem Cells, Advances & Applications

More Market Research Report

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Sterilization Technologies: The U.S. Market
2. Reportlinker Adds Renal Disease Treatments: Products and Therapies
3. Reportlinker Adds Kinase Inhibitors: Global Markets
4. Reportlinker Adds Point of Care Diagnostics
5. Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets
6. Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015
7. Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
8. Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment
9. Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
10. Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report
11. Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... today that nominations will be accepted February 8, 2016 through May 8, ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... Gaithersburg, MD (PRWEB) , ... February 08, 2016 ... ... (AHCC) is excited to share this important news! AHCC and the Home Health ... (AHA) Coding Clinic, CMS' designee for official ICD coding guidance and clarifications, to ...
(Date:2/8/2016)... ... ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal growth ... on February 10th. During this time, people can achieve better health, greater wealth, ... from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
(Date:2/7/2016)... Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... correct pelvic organ prolapse with the latest techniques and the most minimally invasive ... for pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 In a historic vote among ... plans to construct a medical cannabis cultivation facility and dispensary on tribal ... of New York as a provider for patients in the ... York as a provider for patients in the state,s Medical ... 29% (34) to approve the project and pursue designation from the ...
(Date:2/8/2016)... , Feb. 8, 2016 ... the "Knee Reconstruction Devices Market by Product ... Implants), and Geography (U.S., Canada, Eu-5, Japan, Bric, ... 2020" report to their offering. ... of the "Knee Reconstruction Devices Market by ...
(Date:2/8/2016)... , Feb. 8, 2016  The University of ... announced today that, as part of the development ... of the first hospitals in the U.S. to start ... Muraszko , M.D., U-M,s chair of neurosurgery. ... neurosurgery. --> The BrightMatter technology from ...
Breaking Medicine Technology: